NCT03853447 Fibro-inflammatory Progression From Acute to Chronic Pancreatitis
| NCT ID | NCT03853447 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Copenhagen University Hospital, Hvidovre |
| Condition | Pancreatitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2019-02-14 |
| Primary Completion | 2040-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2019-02-14 with a primary completion date of 2040-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Observational prospective study evaluating the developement of chronic pancreatitis based on imaging modalities as well as biochemical markers of inflammation, fibrosis and oxidative stress.
Eligibility Criteria
Inclusion Criteria: * Patients with CP (N=50) of any aetiology except gallstone induced CP: CP will be diagnosed based on MANNHEIM criteria . * Cohort 2: Patients with their first attack of AP of any aetiology except gallstone induced AP (N=50). The revised Atlanta criteria for acute pancreatitis will be used as diagnostic criteria. * Cohort 3: Patients with RAP (N=50) except gallstone induced RAP. RAP is defined as two or more cases of AP as diagnosed by the revised Atlanta Criteria. Exclusion Criteria:
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03853447 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Pancreatitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03853447 currently recruiting?
Yes, NCT03853447 is actively recruiting participants. Contact the research team at srdan.novovic@regionh.dk for enrollment information.
Where is the NCT03853447 trial being conducted?
This trial is being conducted at Hvidovre, Denmark, Aalborg, Denmark, Copenhagen, Denmark.
Who is sponsoring the NCT03853447 clinical trial?
NCT03853447 is sponsored by Copenhagen University Hospital, Hvidovre. The trial plans to enroll 150 participants.